A cancer treatment currently under development promises fewer side effects and less pain for cancer patients. Developed by a team led by Dr. Jay Lazaro of the Institute of Biology, University of the Philippines-Diliman, the treatment uses immunoliposomes as carriers of drugs in cancer therapy. It is currently being tested on mice and part of a project funded by the Department of Science and Technology.
"This kind of breakthrough technology is part of DOST’s drug discovery program for 2012,” says DOST Secretary Mario Montejo. “It lists high in the priorities under the Department's antibody molecular oncology R&D in our search for anti-cancer treatments suitable to Filipinos.”
The more common method of treating cancer, chemotherapy, damages normal cells, so patients experience unpleasant side effects such as nausea, vomiting, allergic reactions, fatigue, weight loss, changes in taste and smell, loss of appetite and hair loss. Therefore, a treatment that affects fewer normal cells will result in fewer side effects.
The immunoliposome method coats cancer-treating drugs with liposomes, or microscopic artificial sacs that can be filled with drugs.
The technology is more specific as it targets only cancer cells. Since there are fewer non-cancer cells affected by the treatment, it results in less toxicity and the patient feels less pain.
READ MORE





















